Pathway Genomics’ Chief Financial Officer, Kamal Adawi, to Present at the 28th Annual Piper Jaffray Healthcare Conference

SAN DIEGO--()--Pathway Genomics, an innovative commercial-stage genomics company, announced today that Kamal Adawi, Chief Financial Officer, will present at the 28th Annual Piper Jaffray Healthcare Conference. This event will be held at The Lotte New York Palace in New York City on Wednesday, November 30, 2016 at 2:10 p.m. ET and the presentation will be made publically available on Pathway.com and Pathway’s social media.

About Pathway Genomics

Founded in 2008, Pathway Genomics offers digital healthcare and genetic testing. Based in San Diego, CA our CLIA and CAP accredited clinical laboratory provides physicians and their patients in 40+ countries with actionable and accurate precision healthcare information to improve health and wellness. The company’s program with IBM Watson is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history.

Pathway believes in the power of “genetics first” to help make proactive, informed decisions about health and lifestyle. Our physician-ordered tests include assays for diet and weight loss, circulating tumor DNA (liquid biopsy), hereditary cancer, pharmacogenomics and carrier screening. For more about Pathway Genomics, visit www.pathway.com and follow us on Facebook, LinkedIn and Twitter.

Contacts

Pathway Genomics
Investor Relations
Kamal Adawi, Chief Financial Officer
858.900.3002
kamal.adawi@pathway.com

Release Summary

Pathway Genomics’ Chief Financial Officer, Kamal Adawi, to Present at the 28th Annual Piper Jaffray Healthcare Conference

Contacts

Pathway Genomics
Investor Relations
Kamal Adawi, Chief Financial Officer
858.900.3002
kamal.adawi@pathway.com